This brief gives an overview of how EGPAF has been working with its affiliated organization in Mozambique to scale up technical capacity of health workers to ensure quality provision of HIV prevention, care and treatment services.
Explore Related Resources
Joana has become a DREAMS Mentor, supporting other young women in pursuit of their dreams. Photo: EGPAF 2022
Journal Articles
Financial Cost Analysis of DREAMS Clinic-Based and Community Programs in Two Provinces of Mozambique, October 2022 to June 2023
Published October 2026
The study showed that investment in DREAMS may improve the employability of AGYW; however, the inclusion of Siyakha packages requires further cost–benefit analysis.
View Resource
Topics:
Adolescents,
Research,
Women
Countries:
Mozambique
February 2022, HEALTH CENTER OF MACIA, Locality Macia, District of Xai Xai, Gaza Province, Mozambique. A doctor smiling AND doctor in a consultation
Journal Articles
HPV Vaccination Uptake and Acceptability of HPV/HIV Integrated Services Models for Adolescent Girls in Mozambique and Zimbabwe
Published June 2026
This study found that integrating HPV vaccination into HIV prevention and treatment services in Mozambique and Zimbabwe significantly increased vaccine uptake among girls at heightened risk of HPV and cervical cancer, while achieving high caregiver acceptance and satisfaction with the integrated care model.
View Resource
Topics:
Adolescents,
HIV
Countries:
Mozambique,
Zimbabwe
February 2022, HEALTH CENTER OF MACIA, Locality Macia, District of Xai Xai, Gaza Province, Mozambique. Delivering a ARVs Bottle in a private pharmacy.
Journal Articles
HIV Drug Resistance Profile in Clients Experiencing Treatment Failure After the Transition to a Dolutegravir-Based First-Line Antiretroviral Treatment Regimen in Mozambique
Published January 2025
Real-world data on HIV drug resistance (HIVDR) after transitioning to tenofovir disoproxil fumarate/lamivudine/dolutegravir (TLD) are limited. We assessed HIVDR rates and patterns in clients with virological failure (VF) after switching from an NNRTI-based regimen to TLD. A cross-sectional study was conducted in Gaza, Mozambique (August 2021–February 2022), including adults on first-line ART for ≥12 months […]
View Resource
Topics:
HIV
Countries:
Mozambique